We previously noted strong induction of genes related to intestinal copper homeostasis (Menkes Copper ATPase (Atp7a) and metallothionein) in the duodenal epithelium of iron-deficient rats across several stages of postnatal development (Collins, J. F., Franck, C. A., Kowdley, K. V., and Ghishan, F. K. (2005) Am. J. Physiol., 288, G964 -G971). We now report significant copper loading in the livers and intestines of iron-deficient rats. These findings are consistent with the hypothesis that there is increased intestinal copper transport during iron deficiency. We additionally found that hepatic Atp7b gene expression does not change with iron deficiency, suggesting that liver copper excretion is not altered. We have developed polyclonal antibodies against rat ATP7A, and we demonstrate the specificity of the immunogenic reaction. We show that the ATP7A protein is present on apical domains of duodenal enterocytes in control rats and on brush-border and basolateral membrane domains in iron-deprived rats. This localization is surprising, as previous in vitro studies have suggested that ATP7A traffics between the trans-Golgi network and the basolateral membrane. We further demonstrate that ATP7A protein levels are dramatically increased in brush-border and basolateral membrane vesicles isolated from iron-deficient rats. Other experiments show that iron refeeding partially corrects the hematological abnormalities seen in iron-deficient rats but that it does not ameliorate ATP7A protein induction, suggesting that Atp7a does not respond to intracellular iron levels. We conclude that ATP7A is involved in copper loading observed during iron deficiency and that increased intestinal copper transport is of physiological relevance, as copper plays important roles in overall body iron homeostasis.
Iron is a component of many proteins that are involved in cellular growth and metabolism. Complex homeostatic mechanisms exist to ensure that adequate iron is available for normal physiological functions while simultaneously avoiding excessive iron accumulation in body tissues. Free iron is highly reactive and is prone to catalyze the formation of toxic oxygen radicals via the Fenton reaction (1) . Iron overload resulting from genetic diseases leads to hepatic fibrosis and cancer, diabetes mellitus, neurodegenerative disorders, and cardiomyopathy (2) . Furthermore, iron deficiency is a major clinical issue, likely afflicting billions of people worldwide, including a large number of people in developed countries such as the United States (3) (4) (5) . Iron deficiency anemia due to low dietary Fe intake results in impaired neurological development and decreased metabolic rate. To avoid iron deficiency and iron overload, iron balance is maintained via precise regulation of intestinal iron transport, which is the site for hormonal regulation of overall body iron homeostasis (6, 7) . This is especially critical for this important trace mineral, as iron excretion is an unregulated, inefficient process.
Within the past few years, several proteins involved in vectorial iron transport across the intestinal epithelium have been isolated and studied. Dietary iron is predominantly in the oxidized, ferric form (Fe 3ϩ ), which is insoluble and has very low bioavailability. Thus, dietary iron is reduced by the brush-border membrane (BBM) 3 ferrireductase, duodenal cytochrome b (DCYTB) (8) to Fe 2ϩ and then transported across the BBM by Divalent Metal Transporter 1 (DMT1) (9) . Once iron has been transported into the cell, it becomes part of the cytosolic iron pool, where it is available for metabolic processes, or is stored in the cytoplasm within ferritin complexes. According to the body's needs, various amounts of free iron traverse the cytoplasm and are transported across the basolateral membrane by the iron exporter ferroportin (10, 11) . In addition to ferroportin, hephaestin (HP) is required for iron transport across the BLM of enterocytes, and it is believed to oxidize Fe 2ϩ to Fe 3ϩ as iron is exported from the cell. Subsequently, oxidized iron can then interact with transferrin in the interstitial fluid, an interaction that mediates iron distribution to cells of the body via the circulatory system. Intestinal iron transport is known to be the "checkpoint" of body iron homeostasis; as such, several physiological effectors are known to modulate this important process. These include erythroid, hypoxia, and inflammatory and stores regulators of intestinal iron transport (1) . We now have some insight into how these various stimuli lead to concerted changes in iron homeostasis and affect intestinal iron transport. Current evidence suggests that all of these physiological cues may modulate the production of hepcidin, a circulating peptide hormone produced by the liver that has pronounced effects on intestinal iron transport (12, 13) . Hepcidin expression may be altered dramatically in response to several known stimuli that alter iron absorption. Conditions that lead to increased iron transport (e.g. iron deficiency, anemia, hypoxia) signal to decrease hepcidin production, whereas conditions that lead to decreased intestinal iron transport (e.g. iron overload, inflammation) induce its expression (14 -16) . Recent in vitro observations have shown that hepcidin binds to the ferroportin protein on the plasma membrane of target cells to induce endocytosis and lysosomal degradation (17) , although other iron transport-related proteins may also be regulated by hepcidin. The iron overload phenotypes of animals and humans deficient in hepcidin further strengthen the supposition that this peptide hormone is a negative regulator of intestinal iron absorption (18, 19) . Furthermore, laboratory rodents overexpressing hepcidin develop a severe anemic phenotype with systemic iron deficiency (20) . Thus, current evidence strongly suggests that hepcidin is a key modulator of intestinal iron transport, a finding that further links intestinal transport with regulation of overall body iron homeostasis.
Copper, like iron, is an essential micronutrient, as demonstrated by nutritional deficiencies and rare genetic disorders (21, 22) . Copper is essential for many physiological processes, including pigmentation, neurotransmitter synthesis, free radical detoxification, mitochondrial oxidative phosphorylation, hemoglobin synthesis, iron metabolism, and intestinal iron transport (23) . Recently, a homolog of the yeast Copper Transporter 1 (CTR1) has been identified in mammalian cells (24) , and it may play a role in the uptake of dietary copper across the apical membrane of enterocytes. However, CTR1 inactivation in mice leads to embryonic lethality (49, 52) , so this possibility remains unproven. There is also in vitro experimental evidence that DMT1 may play a role in brush-border copper transport (25) . Additionally, recent studies suggest that intestinal copper transport is mediated by an unidentified copper ATPase expressed in the apical membrane of intestinal epithelial cells (26) . Once copper enters enterocytes, it may be sequestered in metallothionein (27) (28) (29) , or it may traverse the cytoplasm bound to chaperone proteins and be pumped across the basolateral membrane by the copper ATPase (ATP7A), the mutant gene in Menkes disease (30) . Once copper exits the basal membrane of enterocytes, it is bound to ceruloplasmin (CP), which presumably oxidizes toxic ferrous iron to the ferric form and also functions to distribute copper to the rest of the body via the circulatory system. Cp is thought to play a role in iron release from some tissues, including the liver (31, 32) , and recent studies suggest it may also be important for intestinal iron transport (33) .
The interplay of copper and iron homeostasis has been recognized for more than 150 years, and both trace minerals are required to prevent anemia (34) . This observation has now been confirmed at the molecular level with the discovery of CP and HP, which are multicopper ferroxidases that play roles in iron export from some tissue types (12) . CP is a circulating ferroxidase of hepatic origin, and HP is a membrane-anchored ferroxidase that is important for iron release from duodenal enterocytes. The exact role of CP in intestinal iron absorption has not been resolved conclusively (34) , although some experimental results have shown a positive effect of CP on iron release from enterocytes (35) . Recently, the CP gene was disrupted in mice in an effort to produce an animal model of aceruloplasminemia, which is the lack of CP (17) . The authors of this study concluded that CP loss did not affect intestinal iron absorption, but the low number of mice used and their mixed genetic backgrounds could not rule out an effect of CP on this important physiological process (36) . However, very recent evidence suggests that CP may be important for intestinal iron transport under conditions of increased erythropoiesis (33) . Furthermore, in sex-linked anemic mice, which have inactivating mutations in the HP gene, anemia is seen in younger animals but the anemia is resolved as the animals age, suggesting that another gene becomes active and compensates for the loss of HP (37) .
Our previous studies led us to the discovery that the Menkes copper ATPase is a novel, metal-responsive gene that is strongly induced at the mRNA level by iron deprivation in the duodenum and jejunum of rats at different stages of postnatal development (38, 39) . This finding was of particular interest as copper is known to have the following profound effects on body iron homeostasis: 1) copper is necessary for intestinal iron transport via HP and possibly CP, 2) copper is necessary for iron release from body iron stores in the liver, spleen, and reticuloendothelial macrophages, and 3) copper is necessary for hemoglobin production. Thus, in the current report, we have expanded upon these previous observations to demonstrate that iron-deficient rats have significantly increased intestinal and liver copper levels, suggesting that they absorb increased amounts of dietary copper. Importantly, we have also shown that ATP7A protein expression is also strongly induced by iron deficiency and that the ATP7A protein is present on both brush-border and basolateral domains of duodenal enterocytes. We have further provided experimental evidence that ATP7A induction during iron deficiency is not ameliorated by iron refeeding and partial correction of hematological parameters.
EXPERIMENTAL PROCEDURES
Animal Studies-Sprague-Dawley rats at different stages of postnatal developmental were placed on modified AIN-93G rodent diets that contained either 198 ppm Fe (control diet with the same Fe content as normal rodent chow) or 3 ppm Fe (low Fe diet) for various periods of time (as described in detail previously) (38) . The diets were identical except for the addition of pure ferric citrate to the control Fe diet, and they both had standard copper levels. Suckling (8 days), weanling (21 days), and adolescent (6 weeks) rats were made iron deficient by feeding dams the low Fe diet throughout part or all of gestation and lactation. Soon after birth, litter sizes were normalized by cross-fostering the pups to different dams to maintain a constant dam:pup ratio. For the production of 9-and 12-week-old iron-deficient rats, weaned rats at 3 weeks of age were placed on the control or low diet for 6 -9 weeks, respectively. Some rats were also placed on the diets for 1 year beginning at 8 weeks of age. Livers and intestines were removed from control and iron-deficient rats, and copper and iron analysis was performed by flame atomic absorption spectrometry.
Western Blot Analyses-Brush-border membrane vesicles were prepared by the Mg 2ϩ precipitation method (40, 41) , and basolateral membrane vesicles were prepared by the Percoll density gradient method (42, 43) . The purity of these preps has been addressed extensively in previous publications by us (44 -53) ; moreover, these well established techniques have been utilized by numerous investigators over the past two decades (54 -60) . Membrane proteins were solubilized in Laemmli buffer plus ␤ME, boiled for 5 min, and then separated by SDS/PAGE followed by electroblotting onto nitrocellulose membranes. Western blots were processed as described previously (41, 61, 62 ) with a commercially available antiserum against DMT1 (Alpha Diagnostics) or ATP7A (made by us as described below).
We sought to develop a useful antiserum against the rat ATP7A protein to perform quantitative immunoblot and immunolocalization studies in rat intestine. We were unable to find any published reports of ATP7A antiserum for rat or any commercially available reagents, and surprisingly, we discovered that this protein has never been definitively localized in the mammalian intestine. We thus identified two hydrophilic, potentially antigenic sites in the rat Menkes protein and had two peptides synthesized and co-injected into two rabbits. One site was the carboxyl terminus, and the other was from within the amino-terminal region. The peptide sequences were as follows: NH 2 -KHSLLVGD-FREDDDTTL-COOH, and NH 2 -KKDRSANHLDHKRE-COOH. Rabbits were immunized three times, and a 10-week bleed was utilized for the experiments that are described in this report. Enzyme-linked immunosorbent assay data showed that there was a strong immunogenic response to the carboxyl-terminal peptide in both rabbits, with little immune response generated against the amino-terminal peptide (data not shown). For some experiments, pre-immune serum was utilized, and in others, peptide-blocked antiserum was utilized (see details in the legend of Fig. 5 ).
Immunohistochemical Analysis of Rat Duodenum-Transverse sections (2-4 mm in width) were taken from mid-duodenum of irondeficient and control rats and were placed in 4% paraformaldehyde in phosphate-buffered saline overnight at 4°C. Tissue samples were then transferred to 70% ethanol and embedded in paraffin. 6-m sections were subsequently cut and affixed to microscope slides. Tissue sections were deparrafinized, blocked, and processed with ATP7A antiserum at a 1:100 dilution by standard methods (41, 63) . A fluorescent-tagged secondary antibody (Alexa Fluor 568 goat anti-rabbit IgG (H ϩ L) conjugate; Molecular Probes, Eugene, OR) was utilized at a 1:400 dilution. Staining was visualized by laser scanning confocal microscopy (Bio-Rad MRC 1024) with a 568-nm excitation wavelength and a HQ 598 40 emission filter. Pre-immune serum was also utilized for some experiments.
RESULTS
Iron-deficient rats at the three younger ages were smaller than controls; however, 12-week-and 1-year-old rats were not (data not shown). Phenotype observation and blood analysis of the rats revealed that irondeprived rats at 8 days, 21 days, 6 weeks, and 12 weeks of age showed signs of hypochromic, microcytic anemia (38) (data not shown). However, the 1-year and 8-week-old rats, despite being deprived of dietary iron for 1 year showed no differences between control and iron-deprived groups in any parameters measured with the complete blood count blood test (although there was a non-statistical trend in that direction). We also noted that iron-deficient rats at different developmental stages had significantly increased liver copper levels ( Fig. 1) , whereas liver iron levels were decreased as expected. The liver iron content was as follows (in ppm): for 21-day-old control rats 171.2 Ϯ 14.85 and iron-deficient rats 19.7 Ϯ 0.96 (n ϭ 10/group, p Ͻ0.001); for 1-year and 8-week-old control rats 265.2 Ϯ 35 and iron-deprived rats 58.5 Ϯ 16 for (n ϭ 5/group, p Ͻ0.001). We also measured duodenal and jejunal copper levels by flame atomic absorption spectrometry and found that the intestines of 12-week-old control rats had much lower copper levels than those harvested from iron-deficient rats (in ppm: duodenum, 0.21 Ϯ 0.014 for controls versus 0.82 Ϯ 0.01 for iron-deficient rats, n ϭ 3/group, p Ͻ0.004; jejunum, 0.53 Ϯ 0.007 for controls versus 0.89 Ϯ 0.08 for iron-deficient rats, n ϭ 2-3/group, p ϭ 0.007).
Furthermore, as body copper levels are known to be principally regulated at the level of excretion in the bile, as mediated by the Wilson's copper ATPase (ATP7B), we performed real-time PCR experiments for Atp7b expression in control and iron-deficient rats at different ages.
Our studies showed that there were no alterations in Atp7b mRNA expression between groups (data not shown), suggesting that liver copper excretion was not altered with iron deficiency.
We next performed Western blot analysis of DMT1 protein expression in iron-deficient rats at 6 and 12 weeks of age (Fig. 2) . These experiments showed strong induction of DMT1 expression by iron deficiency in duodenum with little expression in jejunum, as reported by others previously (64, 65) . Interestingly, four transcript splice variants of Dmt1 have been described in the literature, two 5Ј-and two 3Ј-variants. Each of these variants presumably encodes slightly different sized DMT1 proteins. Our data thus suggest that more than one of these variants is likely induced by our dietary feeding strategy, as multiple DMT1 bands could be seen on Westerns. Furthermore, post-translational modification of DMT1 likely occurs, and many investigators have also detected multiple DMT1 bands on immunoblots. These studies also showed that rats were indeed iron deficient, as rats with normal iron status have little detectable DMT1 protein. Furthermore, these immunoblots demonstrate the fact that our brush-border membrane preparation method is indeed highly enriched for brush-border membranes, as this is where DMT1 is expressed within enterocytes. Importantly, this same vesicle purification method was utilized for Western blot analysis of ATP7A protein expression, which led us to the novel observation that ATP7A is expressed on the apical membranes of duodenal enterocytes and that ATP7A protein on the brush-border is greatly increased by dietary iron deprivation (as described in detail below).
A preliminary experiment demonstrated that there was strong induction of ATP7A protein expression in crude membrane proteins isolated from a group of 12-week-old iron-deficient rats versus normal controls (data not shown). This finding led us to believe that our antiserum would be useful to study ATP7A protein expression levels in our experimental model of iron deficiency. We thus preformed a series of immunohistochemistry (IHC) experiments with ATP7A and Na ϩ /K ϩ ATPase antisera in weanling and adult iron-deficient rats (Figs. 3 and 4) . These experiments clearly demonstrated that the ATP7A protein was predominantly localized to the apical membrane of enterocytes in control rats and was present on both brush-border and basolateral membranes in iron-deficient rats at two different ages. The localization to the apical membrane of enterocytes was unexpected, as previous in vitro studies have suggested that ATP7A traffics between an intracellular compartment (e.g. the trans-Golgi network) and the basolateral membrane upon copper loading when expressed in polarized renal epithelial cells (66) and in other cell types (67) (68) (69) . Furthermore, Na ϩ /K ϩ ATPase protein was localized exclusively to basolateral membrane domains as expected, and ATP7A pre-immune serum did not detect any immunoreactive proteins in the intestinal villus from either control or iron- Liver copper levels in iron-deficient rats were significantly increased as compared with controls. The number of livers studied is as follows: for 21-day old rats, 10 controls and 10 iron deficient; for 9-week-old rats, 9 controls and 9 iron deficient; for 12-week-old rats, 20 controls and 20 iron deficient. *, p Ͻ0.05 between groups. Numbers on the Y axis are in ppm.
deficient rats. These observations confirmed the validity of these studies.
We next sought to perform immunoblots to accurately quantitate ATP7A protein expression levels in iron-deficient rats at different postnatal ages, as IHC is semi-quantitative at best. We performed experiments to define the specificity of this immunogenic reaction and to confirm observations made by IHC experiments. First, we purified BBMV from iron-deficient and control rats and performed Western blots with the 10-week immune bleed from one of the immunized rabbits. These experiments showed detection of a strong band at ϳ180 kDa that was only seen in the iron-deficient group. We also determined that the reaction could be blocked by pretreatment of the antiserum with the carboxyl-terminal, antigenic peptide (because this was the one that enzyme-linked immunosorbent assay data showed had generated the immune response) and that the pre-immune serum did not detect any protein bands in either group (Fig. 5) .
Our next series of experiments was designed to determine whether ATP7A could also be detected in a pure prep of basolateral membranes. We harvested duodenal mucosa from control and iron-deficient rats and utilized a well established basolateral membrane prep method that involves removing enterocytes by palpation of gut segments filled with a citrate buffer, followed by Percoll density centrifugation. The resulting membrane vesicles are highly enriched for basolateral membrane protein markers and have little contamination with brush-border membrane vesicles (42, 43) . Western blot analysis of these basolateral membrane vesicle proteins was performed, and strong induction of ATP7A protein expression was also detected in iron-deficient rats (Fig. 6 ). For this experiment, antiserum against the Na ϩ /K ϩ ATPase was used as a constitutive control as it is known to be localized to only basolateral domains in the intestinal epithelium. Pre-immune serum again did not detect any proteins in basolateral membrane vesicle proteins. We next sought to quantitate ATP7A protein expression in the brush-border membrane of iron-deficient rats at different postnatal ages, as previous studies of Atp7a mRNA expression had shown regulation throughout postnatal development (38) . We produced iron-deficient rats at different stages of postnatal development and performed Western blot analyses with BBMV (Fig. 7) . Results showed that ATP7A protein expression was strongly induced by iron deprivation in 21-day-, FIGURE 2. Western blot analysis of DMT1 protein expression in the duodenum and jejunum of iron-deficient rats. Intestinal mucosa was harvested from groups of rats, and brush-border membrane vesicle proteins were purified by the well established Mg 2ϩ precipitation method. SDS/PAGE followed by immunoblotting was subsequently performed with a 1:4000 dilution of the DMT1 antiserum. As shown, significant induction of DMT1 was seen in 6-and 12-week-old iron-deficient rats, and a modest induction was also detected in the jejunum of a group of 12-week-old iron-deficient rats. FIGURE 3. Immunohistochemical analysis of 12-week-old rat duodenum. Tissue sections were processed for IHC and reacted with a 1:100 dilution of pre-immune serum, serum from a 10-week immune bleed against ATP7A, or a commercially available antiserum against the rat Na ϩ /K ϩ ATPase. A fluorescent-tagged secondary antibody was used, and slides were imaged with a Bio-Rad MRC 1024 laser scanning confocal microscope utilizing identical settings for imaging of each slide within each individual experiment. Pre-immune serum showed minimal staining, whereas the ATP7A immune serum showed strong staining of brush-border membranes (in control and iron-deficient rats) and basolateral membranes (stronger in iron-deficient rats). As expected, Na ϩ /K ϩ ATPase antiserum showed only basal and lateral staining. This figure is representative of several experiments that were performed, with very similar results.
FIGURE 4.
Immunohistochemical analysis of ATP7A expression in 21-day-old rat duodenum. Tissues were processed and images were captured as described in the legend to Fig. 3 . Identical results were obtained as those seen in 12-week-old rats, in which brush-border staining was present in both control and iron-deficient samples whereas basolateral staining was much stronger in the iron-deficient rats. One representative experiment is shown.
FIGURE 5. Western blot analysis of ATP7A protein expression in BBM vesicles isolated from 12-week-old rats. Western blots were processed with ATP7A immune serum, pre-immune serum, or antigen-blocked immune serum. A single band at ϳ180 kDa was detected only in the low Fe group, and it was blockable by preincubation of the antiserum with the immunogenic peptide (1 mg peptide/ml serum, 2 h at 15°C). Preimmune serum also did not detect this protein band. As seen, very little immunoreactive protein was detected in the control groups, even with overexposure of the blots (not shown). C, control; L, low Fe.
6-week-, 12-week-, and 60-week-old rats and that immunoreactive protein was barely detectable in control rats at all ages. Our final experiment was designed to determine the effect that iron refeeding would have on expression of ATP7A protein expression in iron-deficient rats. We produced a group of iron-deficient rats, fed half the group the control iron diet for 5 days, and left the remaining rats on the iron-deficient diet. We then purified BBMV and performed Western blot analysis (Fig. 8B) . Interestingly, we found that iron refeeding corrected the hematological abnormalities seen in the rats (Fig. 8A ) but had no effect on ATP7A protein expression levels.
DISCUSSION
To identify novel genes associated with the important physiological process of intestinal iron transport, we initially induced iron deficiency in groups of rats at various stages of postnatal development and performed microarray experiments (38, 39) . This is a logical approach, as many genes involved in iron transport and homeostasis are known to be induced by iron deprivation. We found that in addition to many known iron-responsive genes, several novel genes were induced by dietary iron deprivation, including genes related to intestinal copper homeostasis (Menkes Copper ATPase (Atp7a) and metallothionein). Induction of Atp7a at different ages was confirmed by quantitative, real-time PCR (30) . We thus hypothesized that up-regulation of Atp7a was of potential physiological relevance, as there is a well known link between iron and copper in body iron homeostasis. Furthermore, we were intrigued by the fact that Atp7a was coordinately regulated by iron deficiency along with several known iron transport-related genes including Dmt1, Dcytb, transferrin receptor 1, and heme oxygenase 1 (38) .
We next measured intestinal and liver copper levels in iron-deficient rats at different ages and noted that there were significantly increased copper levels in these two tissues. This finding suggested that irondeprived rats were absorbing increased amounts of dietary copper, which is consistent with the observation that Atp7a was significantly induced, given its known role in intestinal copper transport. However, the possibility remained that liver copper excretion was also altered, as body copper homeostasis is controlled at the level of excretion into the bile. This process is mediated by the ATP7B copper ATPase, the mutant gene in Wilson disease. We thus measured Atp7b mRNA expression levels by quantitative real-time PCR and found in multiple experiments at different ages that Atp7b gene expression was not altered during iron deficiency. Additionally, as expected, iron-deprived rats had decreased liver iron levels.
Our next objective was to determine whether increases in Atp7a mRNA were paralleled by increases in protein expression. We first determined that there were no published reports of ATP7A antiserum against the rat protein and no commercial reagents were available. Thus, we sought to develop our own rat, ATP7A -specific antiserum by immunizing two rabbits with ATP7A -specific peptides. We chose sites of the rat ATP7A protein that were highly hydrophilic and potentially antigenic, based upon several computer prediction programs. Enzymelinked immunosorbent assay data from the rabbit serum showed that one rabbit in particular generated a very strong immune response to the carboxyl-terminal peptide by the second immunization; we thus chose to perform initial experiments with a 10-week bleed from this rabbit. Utilizing this serum, we demonstrated that ATP7A protein expression is strongly induced in protein samples isolated from both brush-border and basolateral membrane vesicles of iron-deficient rats. In BBM vesicles, we demonstrated that the protein is strongly induced across several stages of postnatal development, which is consistent with previous observations made by microarray and real-time PCR analyses (38) . These antibodies have also been used in immunohistochemical studies to demonstrate that the ATP7A protein is expressed on both apical and basolateral membrane domains in both control and iron-deficient rats, suggesting that it may play an important role in intestinal copper transport during normal physiological circumstances. We have also conclusively demonstrated that the antiserum is specific for ATP7A, as in control experiments the immunodetection was blocked with the antigenic peptide and there was no protein detection with pre-immune serum by Western blot or immunohistochemical analysis in multiple experiments.
This series of IHC and Western blot experiments strongly suggested that Atp7a is a metal-responsive gene that is coordinately regulated along with known iron-responsive genes such as Dmt1 and Dcytb. We also felt that these observations justified further analysis of Atp7a expression and activity to decipher the physiological role of this protein FIGURE 6 . Western blot analysis of ATP7A protein expression in basolateral membrane vesicles (BLMV) isolated from 12-week-old rats. Western blots were processed with ATP7A immune serum and pre-immune serum. In this experiment, two large molecular mass protein bands were detected only in the iron-deficient sample (two bands were observed in some experiments). Both bands were absent when the pre-immune serum was used, and they were blockable by the antigenic peptide (not shown). They may thus represent different molecular forms of the ATP7A protein. These results confirmed the observations made with IHC experiments (shown above) in which little ATP7A protein is present on the basolateral membrane in control rats and there is a strong induction with iron deficiency. One representative experiment is shown of three that were performed with identical results. Na ϩ /K ϩ ATPase antiserum was utilized as a constitutively expressed basolateral-specific control. In some experiments, we also used ␤-actin as a control (not shown). C, control; L, low Fe. FIGURE 7. Western blot analysis of ATP7A protein expression in brush-border membrane vesicles isolated from rat duodenum at different stages of postnatal development. Rats were made iron deficient by dietary iron deprivation. BBMVs were prepared from duodenal scrapes by a standard method, and Western blots were processed with ATP7A 10-week immune serum and pre-immune serum. A strong immunoreactive band at ϳ180 kDa was detected in all iron-deficient groups but was absent in controls. Pre-immune serum did not detect any protein bands in any samples (not shown). Each age and treatment group consists of a group of three to six rats. C, control; L, low Fe.
in intestinal metal ion homeostasis under normal and iron-deficient conditions. To this point, several novel observations have been documented: 1) ATP7A is present on the brush-border membrane of duodenal enterocytes, a localization that is congruent with it being involved in copper and/or iron transport; 2) Atp7a gene expression is induced by iron deficiency, an observation that is intriguing, as regulation of Atp7a gene expression has not been previously described in the scientific literature (only protein trafficking in response to copper loading); and 3) ATP7A protein expression is also strongly induced during iron deprivation, and the immunoreactive protein is localized on both apical and basolateral membrane domains. We further noted that other novel genes are coordinately regulated along with Atp7a and known ironresponsive proteins (Dmt1, Dcytb, TfR1), suggesting that this group of genes likely plays an important physiological role related to intestinal metal ion homeostasis.
Many apically expressed nutrient transporters are known to be acutely regulated by membrane recycling whereby they are physically removed from the plasma membrane of cells under certain physiological circumstances. The same phenomenon has been described for some iron transport-related proteins. For instance, DMT1 is rapidly internalized from the brush-border membrane by feeding iron-deficient rats a bolus of iron (70) , and Dmt1 gene expression is also rapidly downregulated by iron refeeding. These observations suggest that Dmt1 responds to intracellular iron levels rather than to systemic iron status. Thus, we sought to determine whether induction of ATP7A expression on the apical membrane of enterocytes by iron deficiency could be reversed by refeeding iron to iron-deficient rats. We placed a group of weanling rats on a low iron diet for 9 -10 weeks and then took half the group and put them back on the control diet (with 198 ppm Fe) for 5 days while the other half remained on the low Fe diet. Interestingly, iron refeeding did not ameliorate the induction of ATP7A protein expression on the BBM of duodenal enterocytes. These data suggested that ATP7A expression was not responding to intracellular iron levels like DMT1 but rather to systemic cues most likely related to body iron levels. Alternatively, ATP7A induction could be related to increased intracellular copper levels, although copper-mediated regulation of Atp7a gene expression has never been described.
Furthermore, as copper and iron homeostasis are intimately intertwined, it seemed very likely that increased copper absorption during iron deficiency was a specific response intended to somehow compensate for decreased body iron levels. In fact, copper is known to be related to the following physiological functions: 1) intestinal iron transport as mediated by two multicopper ferroxidases (ceruloplasmin and hephaestin), 2) iron release from body iron stores in the liver and reticuloendothelial macrophages, and 3) iron loading into hemoglobin. It is also conceivable that copper could substitute for iron in other iron-containing proteins, such as mitochondrial cytochromes involved in respiration. We thus hypothesized that the sustained induction of ATP7A after correction of the hematological abnormalities from iron deprivation was clear evidence that this phenomenon was not a secondary effect of iron deficiency but rather a primary physiological response.
In summary, our previous studies led to the observation that changes in the expression of intestinal metal ion transporters (e.g. iron, copper) occur with iron deprivation. Based upon these initial observations, we sought to test the hypothesis that several of these coordinately regulated, metal-responsive genes, including Dmt1, Dcytb, and Atp7a, play key roles in intestinal metal ion homeostasis. Our original observations at the genetic level have been confirmed by several complementary experimental approaches. These include measurement of tissue metal levels and hematological analyses of blood parameters related to iron status, real-time PCR studies, and immunohistochemical and Western blot analyses. We have demonstrated that copper levels are significantly increased in the livers and intestines of iron-deficient rats and that expression of the principal liver copper exporter, Atp7b, is not altered during iron deficiency. Thus, increased copper transport likely occurs during iron deficiency. We have further developed antibodies against the Menkes copper ATPase, which demonstrated strong induction of protein expression in brush-border and BLM vesicles across several stages of postnatal development and immunolocalization of ATP7A protein to apical and basolateral membrane domains in duodenal enterocytes. Overall, these findings demonstrate that many aspects of intestinal metal ion homeostasis are still not clearly defined. Future studies will thus be intended to further increase our understanding of the complex regulatory mechanisms involved in intestinal iron and copper transport and how these processes contribute to overall body metal ion homeostasis.
